Checking authentication...
Pharmed Limited Shares
Pharmed Limited, established in 1946 and headquartered in Bangalore, India, is recognized as one of the fastest-growing pharmaceutical companies in the country. The company focuses on manufacturing a wide range of evidence-based pharmaceutical and nutraceutical products, primarily targeting specialized therapy areas such as women's health, orthopedic health, pain management, and general healthcare. Its commitment to quality and innovation has led to the introduction of several "first-time in India" brands
Fundamentals
Financial (In Cr)
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 359.6 | 425.99 | 436 | - |
| Cost of Material Consumed | - | - | - | - |
| Gross Margins | - | - | - | - |
| Change in Inventory | - | - | - | - |
| Employee Benefit Expenses | 97.79 | 129.79 | - | - |
| Other Expenses | - | - | - | - |
| EBITDA | - | - | - | - |
| OPM | - | - | - | - |
| Other Income | 9.45 | 9.98 | 9.98 | - |
| Finance Cost | 0.36 | 0.3 | 0.36 | - |
| D&A | 2.32 | 3.27 | 3.27 | - |
| EBIT | 55.02 | 43.1 | 43.1 | - |
| EBIT Margins | - | - | - | - |
| PBT | 55.02 | 43.1 | 43.1 | - |
| PBT Margins | - | - | - | - |
| Tax (2021) | - | - | - | - |
| PAT | 42.3 | 33 | 9.36 | |
| NPM | - | - | - | - |
| EPS | - | - | - | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | - | - | - | - |
| Net Profit Margin | 0.1176 | 0.1208 | 0.0777 | - |
| Earning Per Share (Diluted) | ₹76.54 | ₹98.27 | ₹76.54 | - |
Shareholding Pattern
| Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Individuals | - | - | - | - |
| Corporated Listed | - | - | - | - |
| Corporated Unlisted | - | - | - | - |
| Financial Institutions/Banks | - | - | - | - |
| Insurance Companies | - | - | - | - |
| Venture Capital Fund/AIFs | - | - | - | - |
| Foreign Holding | - | - | - | - |
| Others | - | - | - | - |
Promoters
| Promoters | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Suneet Aurora | Chairman and Managing Director | 30+ | in |
| Yogesh Saran Aurora | Board Member | 40+ | - |
| Dr. Jagdish Chinnappa | Independent Director | 20+ | - |
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
